Tvardi Therapeutics (TVRD) Stock Chart & Stock Price History $35.27 -2.97 (-7.77%) As of 01:33 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tvardi Therapeutics Stock Price Performance The Tvardi Therapeutics (TVRD) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 25.74%, reflecting recent market activity. As of the latest close, Tvardi Therapeutics traded at $38.24 with a market cap of $358.58 million and volume of 245,923 shares. Receive TVRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-9.66%1 Month Performance+25.74%3 Month Performance+36.86% TVRD Stock Chart for Monday, September, 22, 2025 TVRD Chart by TradingView Tvardi Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/19/2025$38.74$38.24-1.29%$39.71$36.99245,923 shs$358.58 million09/18/2025$39.04$38.74-0.77%$40.77$37.7076,536 shs$363.38 million09/17/2025$33.83$39.04+15.40%$39.04$34.16134,790 shs$366.20 million09/16/2025$33.76$33.83+0.21%$35.20$33.5132,459 shs$317.22 million09/15/2025$33.88$33.76-0.35%$35.39$33.6023,559 shs$316.67 million09/12/2025$35.40$33.88-4.29%$36.71$33.2239,705 shs$317.79 million09/11/2025$32.84$35.40+7.80%$35.80$32.3129,644 shs$332.05 million09/10/2025$31.82$32.84+3.21%$33.00$31.2120,833 shs$307.94 million09/09/2025$29.66$31.82+7.28%$31.84$29.3322,407 shs$298.47 million09/08/2025$31.11$29.66-4.66%$31.11$29.4322,714 shs$278.21 million Get the Latest News and Ratings for TVRD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/05/2025$30.44$31.11+2.20%$31.88$30.2413,827 shs$291.81 million09/04/2025$28.76$30.44+5.84%$30.65$28.7517,863 shs$285.44 million09/03/2025$29.58$28.76-2.77%$30.09$28.2017,166 shs$269.77 million09/02/2025$29.92$29.58-1.14%$30.37$29.2216,948 shs$277.46 million09/01/2025$29.92$29.92$30.69$29.2914,257 shs$280.56 million08/29/2025$30.27$29.92-1.16%$30.69$29.2914,257 shs$280.56 million08/28/2025$30.59$30.27-1.05%$31.54$29.0721,349 shs$283.93 million08/27/2025$29.21$30.59+4.72%$30.79$28.8834,182 shs$286.93 million08/26/2025$29.20$29.21+0.03%$29.68$28.1316,769 shs$273.90 million08/25/2025$28.05$29.20+4.10%$29.93$27.5227,250 shs$273.90 million08/22/2025$26.65$28.05+5.25%$29.00$26.7442,712 shs$263.11 million08/21/2025$26.88$26.65-0.86%$27.20$25.5426,391 shs$249.98 million Related Companies Cogent Biosciences Stock Price Chart Schrodinger Stock Price Chart AbCellera Biologics Stock Price Chart Tilray Brands Stock Price Chart Xeris Biopharma Stock Price Chart Structure Therapeutics Stock Price Chart Syndax Pharmaceuticals Stock Price Chart Evotec Stock Price Chart Arcus Biosciences Stock Price Chart Stoke Therapeutics Stock Price Chart Receive TVRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TVRD) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tvardi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tvardi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TVRD Stock Alerts